Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127435232 | 12743523 | 2 | F | 20150629 | 20160913 | 20160914 | 20160915 | EXP | FR-TAKEDA-2016MPI008019 | TAKEDA | 70.00 | YR | M | Y | 0.00000 | 20160915 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127435232 | 12743523 | 1 | PS | VELCADE | BORTEZOMIB | 1 | Unknown | UNK | D | 21602 | INJECTION | ||||||||
| 127435232 | 12743523 | 2 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | 7.5 MG, QD | 0 | 7.5 | MG | QD | |||||||
| 127435232 | 12743523 | 3 | SS | ENDOXAN /00021101/ | CYCLOPHOSPHAMIDE | 1 | Unknown | UNK | D | 0 | |||||||||
| 127435232 | 12743523 | 4 | SS | NEORAL | CYCLOSPORINE | 1 | Oral | 125 MG, BID | 0 | 125 | MG | BID | |||||||
| 127435232 | 12743523 | 5 | SS | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | Oral | 1250 MG, QD | 0 | 1250 | MG | QD | |||||||
| 127435232 | 12743523 | 6 | C | LERCAN | LERCANIDIPINE | 1 | Unknown | UNK | D | 0 | |||||||||
| 127435232 | 12743523 | 7 | C | HYPERIUM | RILMENIDINE PHOSPHATE | 1 | Unknown | UNK | D | 0 | |||||||||
| 127435232 | 12743523 | 8 | C | TEMERIT | NEBIVOLOL | 1 | Unknown | UNK | D | 0 | |||||||||
| 127435232 | 12743523 | 9 | C | ALPRESS | PRAZOSIN | 1 | Unknown | UNK | D | 0 | |||||||||
| 127435232 | 12743523 | 10 | C | UVEDOSE | CHOLECALCIFEROL | 1 | Unknown | UNK | D | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127435232 | 12743523 | 1 | Nephropathy |
| 127435232 | 12743523 | 2 | Renal failure |
| 127435232 | 12743523 | 3 | Nephropathy |
| 127435232 | 12743523 | 4 | Prophylaxis against transplant rejection |
| 127435232 | 12743523 | 5 | Prophylaxis against transplant rejection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127435232 | 12743523 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127435232 | 12743523 | Neuroendocrine carcinoma of the skin | |
| 127435232 | 12743523 | Off label use | |
| 127435232 | 12743523 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127435232 | 12743523 | 1 | 20150629 | 20160209 | 0 | |
| 127435232 | 12743523 | 2 | 20160623 | 0 | ||
| 127435232 | 12743523 | 3 | 20150629 | 20160209 | 0 |